nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafcillin—CYP1A2—Sorafenib—liver cancer	0.119	0.543	CbGbCtD
Nafcillin—CYP3A4—Sorafenib—liver cancer	0.0623	0.284	CbGbCtD
Nafcillin—CYP3A4—Doxorubicin—liver cancer	0.0378	0.173	CbGbCtD
Nafcillin—Tubulointerstitial nephritis—Sorafenib—liver cancer	0.0202	0.0396	CcSEcCtD
Nafcillin—Proteinuria—Sorafenib—liver cancer	0.0176	0.0345	CcSEcCtD
Nafcillin—Protein urine present—Sorafenib—liver cancer	0.0174	0.034	CcSEcCtD
Nafcillin—Skin necrosis—Epirubicin—liver cancer	0.0164	0.0321	CcSEcCtD
Nafcillin—Sensitisation—Epirubicin—liver cancer	0.016	0.0314	CcSEcCtD
Nafcillin—Skin necrosis—Doxorubicin—liver cancer	0.0152	0.0297	CcSEcCtD
Nafcillin—Sensitisation—Doxorubicin—liver cancer	0.0148	0.029	CcSEcCtD
Nafcillin—Skin exfoliation—Sorafenib—liver cancer	0.0148	0.0289	CcSEcCtD
Nafcillin—CYP3A4—Felbamate Metabolism—CYP2E1—liver cancer	0.0135	0.0499	CbGpPWpGaD
Nafcillin—CYP1A2—Arylamine metabolism—NAT2—liver cancer	0.0111	0.0412	CbGpPWpGaD
Nafcillin—Local reaction—Epirubicin—liver cancer	0.0103	0.0202	CcSEcCtD
Nafcillin—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.0101	0.0198	CcSEcCtD
Nafcillin—Local reaction—Doxorubicin—liver cancer	0.00957	0.0187	CcSEcCtD
Nafcillin—Abdominal discomfort—Sorafenib—liver cancer	0.00932	0.0182	CcSEcCtD
Nafcillin—Neutropenia—Sorafenib—liver cancer	0.00909	0.0178	CcSEcCtD
Nafcillin—Renal failure—Sorafenib—liver cancer	0.00852	0.0167	CcSEcCtD
Nafcillin—Bone marrow depression—Epirubicin—liver cancer	0.00848	0.0166	CcSEcCtD
Nafcillin—Stomatitis—Sorafenib—liver cancer	0.00845	0.0165	CcSEcCtD
Nafcillin—CYP3A4—Liver X Receptor Pathway—SCD—liver cancer	0.0081	0.03	CbGpPWpGaD
Nafcillin—Bone marrow depression—Doxorubicin—liver cancer	0.00785	0.0154	CcSEcCtD
Nafcillin—Necrosis—Epirubicin—liver cancer	0.0073	0.0143	CcSEcCtD
Nafcillin—Necrosis—Doxorubicin—liver cancer	0.00675	0.0132	CcSEcCtD
Nafcillin—Extravasation—Epirubicin—liver cancer	0.00656	0.0128	CcSEcCtD
Nafcillin—Angioedema—Sorafenib—liver cancer	0.00619	0.0121	CcSEcCtD
Nafcillin—Extravasation—Doxorubicin—liver cancer	0.00607	0.0119	CcSEcCtD
Nafcillin—Inflammation—Epirubicin—liver cancer	0.0059	0.0115	CcSEcCtD
Nafcillin—Myalgia—Sorafenib—liver cancer	0.00577	0.0113	CcSEcCtD
Nafcillin—Arthralgia—Sorafenib—liver cancer	0.00577	0.0113	CcSEcCtD
Nafcillin—Anaphylactic shock—Sorafenib—liver cancer	0.00553	0.0108	CcSEcCtD
Nafcillin—Skin exfoliation—Epirubicin—liver cancer	0.00547	0.0107	CcSEcCtD
Nafcillin—Inflammation—Doxorubicin—liver cancer	0.00546	0.0107	CcSEcCtD
Nafcillin—Shock—Sorafenib—liver cancer	0.00544	0.0106	CcSEcCtD
Nafcillin—Skin exfoliation—Doxorubicin—liver cancer	0.00506	0.00989	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00504	0.00985	CcSEcCtD
Nafcillin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00486	0.018	CbGpPWpGaD
Nafcillin—Phlebitis—Epirubicin—liver cancer	0.00483	0.00944	CcSEcCtD
Nafcillin—Thrombophlebitis—Epirubicin—liver cancer	0.0048	0.00939	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Sorafenib—liver cancer	0.00477	0.00934	CcSEcCtD
Nafcillin—Pain—Sorafenib—liver cancer	0.00473	0.00925	CcSEcCtD
Nafcillin—CYP1A2—Estrogen metabolism—GSTA1—liver cancer	0.00467	0.0173	CbGpPWpGaD
Nafcillin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00457	0.0169	CbGpPWpGaD
Nafcillin—Gastrointestinal pain—Sorafenib—liver cancer	0.00452	0.00884	CcSEcCtD
Nafcillin—Phlebitis—Doxorubicin—liver cancer	0.00446	0.00873	CcSEcCtD
Nafcillin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.00446	0.0165	CbGpPWpGaD
Nafcillin—Thrombophlebitis—Doxorubicin—liver cancer	0.00444	0.00869	CcSEcCtD
Nafcillin—Urticaria—Sorafenib—liver cancer	0.00439	0.00859	CcSEcCtD
Nafcillin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00439	0.0163	CbGpPWpGaD
Nafcillin—Abdominal pain—Sorafenib—liver cancer	0.00437	0.00855	CcSEcCtD
Nafcillin—Body temperature increased—Sorafenib—liver cancer	0.00437	0.00855	CcSEcCtD
Nafcillin—Renal impairment—Epirubicin—liver cancer	0.00437	0.00854	CcSEcCtD
Nafcillin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00436	0.0162	CbGpPWpGaD
Nafcillin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—liver cancer	0.00414	0.0153	CbGpPWpGaD
Nafcillin—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.00408	0.0151	CbGpPWpGaD
Nafcillin—Hypersensitivity—Sorafenib—liver cancer	0.00407	0.00797	CcSEcCtD
Nafcillin—Renal impairment—Doxorubicin—liver cancer	0.00404	0.00791	CcSEcCtD
Nafcillin—Pruritus—Sorafenib—liver cancer	0.00391	0.00765	CcSEcCtD
Nafcillin—Liver function test abnormal—Epirubicin—liver cancer	0.00384	0.00751	CcSEcCtD
Nafcillin—Diarrhoea—Sorafenib—liver cancer	0.00378	0.0074	CcSEcCtD
Nafcillin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—liver cancer	0.00376	0.014	CbGpPWpGaD
Nafcillin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00375	0.0139	CbGpPWpGaD
Nafcillin—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00374	0.00732	CcSEcCtD
Nafcillin—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.0036	0.0134	CbGpPWpGaD
Nafcillin—Eosinophilia—Epirubicin—liver cancer	0.00356	0.00696	CcSEcCtD
Nafcillin—Liver function test abnormal—Doxorubicin—liver cancer	0.00355	0.00695	CcSEcCtD
Nafcillin—Vomiting—Sorafenib—liver cancer	0.00352	0.00688	CcSEcCtD
Nafcillin—Rash—Sorafenib—liver cancer	0.00349	0.00682	CcSEcCtD
Nafcillin—Dermatitis—Sorafenib—liver cancer	0.00348	0.00681	CcSEcCtD
Nafcillin—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00346	0.00677	CcSEcCtD
Nafcillin—Pancytopenia—Epirubicin—liver cancer	0.00341	0.00667	CcSEcCtD
Nafcillin—Neutropenia—Epirubicin—liver cancer	0.00336	0.00657	CcSEcCtD
Nafcillin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00332	0.0123	CbGpPWpGaD
Nafcillin—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00331	0.0123	CbGpPWpGaD
Nafcillin—Eosinophilia—Doxorubicin—liver cancer	0.00329	0.00644	CcSEcCtD
Nafcillin—Nausea—Sorafenib—liver cancer	0.00328	0.00642	CcSEcCtD
Nafcillin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00327	0.0121	CbGpPWpGaD
Nafcillin—Pancytopenia—Doxorubicin—liver cancer	0.00316	0.00618	CcSEcCtD
Nafcillin—Renal failure—Epirubicin—liver cancer	0.00315	0.00616	CcSEcCtD
Nafcillin—Stomatitis—Epirubicin—liver cancer	0.00312	0.00611	CcSEcCtD
Nafcillin—Neutropenia—Doxorubicin—liver cancer	0.00311	0.00608	CcSEcCtD
Nafcillin—Haematuria—Epirubicin—liver cancer	0.00305	0.00597	CcSEcCtD
Nafcillin—Agranulocytosis—Epirubicin—liver cancer	0.00299	0.00585	CcSEcCtD
Nafcillin—Renal failure—Doxorubicin—liver cancer	0.00291	0.0057	CcSEcCtD
Nafcillin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.00291	0.0108	CbGpPWpGaD
Nafcillin—Stomatitis—Doxorubicin—liver cancer	0.00289	0.00565	CcSEcCtD
Nafcillin—Haematuria—Doxorubicin—liver cancer	0.00283	0.00553	CcSEcCtD
Nafcillin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—liver cancer	0.00281	0.0104	CbGpPWpGaD
Nafcillin—Agranulocytosis—Doxorubicin—liver cancer	0.00277	0.00541	CcSEcCtD
Nafcillin—CYP1A2—Xenobiotics—CYP2E1—liver cancer	0.00277	0.0103	CbGpPWpGaD
Nafcillin—CYP1A2—Tamoxifen metabolism—CYP2E1—liver cancer	0.00266	0.00986	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—UGDH—liver cancer	0.00266	0.00985	CbGpPWpGaD
Nafcillin—CYP1A2—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00265	0.00981	CbGpPWpGaD
Nafcillin—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00265	0.00981	CbGpPWpGaD
Nafcillin—CYP1A2—Estrogen Receptor Pathway—PPARA—liver cancer	0.00257	0.00951	CbGpPWpGaD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00256	0.0095	CbGpPWpGaD
Nafcillin—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00255	0.00946	CbGpPWpGaD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00252	0.00934	CbGpPWpGaD
Nafcillin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00238	0.00881	CbGpPWpGaD
Nafcillin—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.00236	0.00874	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—liver cancer	0.00234	0.00869	CbGpPWpGaD
Nafcillin—CYP1A2—Estrogen Receptor Pathway—ESR1—liver cancer	0.00232	0.00862	CbGpPWpGaD
Nafcillin—Ill-defined disorder—Epirubicin—liver cancer	0.00232	0.00454	CcSEcCtD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—GSTA2—liver cancer	0.00229	0.00847	CbGpPWpGaD
Nafcillin—CYP1A2—Estrogen metabolism—GSTM1—liver cancer	0.00228	0.00846	CbGpPWpGaD
Nafcillin—Malaise—Epirubicin—liver cancer	0.00226	0.00442	CcSEcCtD
Nafcillin—CYP1A2—Estrogen metabolism—CYP1A1—liver cancer	0.00216	0.00802	CbGpPWpGaD
Nafcillin—Ill-defined disorder—Doxorubicin—liver cancer	0.00215	0.0042	CcSEcCtD
Nafcillin—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00213	0.00792	CbGpPWpGaD
Nafcillin—Myalgia—Epirubicin—liver cancer	0.00213	0.00417	CcSEcCtD
Nafcillin—Arthralgia—Epirubicin—liver cancer	0.00213	0.00417	CcSEcCtD
Nafcillin—CYP1A2—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00211	0.00782	CbGpPWpGaD
Nafcillin—Discomfort—Epirubicin—liver cancer	0.00211	0.00412	CcSEcCtD
Nafcillin—Malaise—Doxorubicin—liver cancer	0.00209	0.00409	CcSEcCtD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00207	0.00769	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00206	0.00764	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00206	0.00764	CbGpPWpGaD
Nafcillin—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.00205	0.00761	CbGpPWpGaD
Nafcillin—Anaphylactic shock—Epirubicin—liver cancer	0.00204	0.004	CcSEcCtD
Nafcillin—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00204	0.00757	CbGpPWpGaD
Nafcillin—Shock—Epirubicin—liver cancer	0.00201	0.00393	CcSEcCtD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—AHR—liver cancer	0.00199	0.00739	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—liver cancer	0.00199	0.00739	CbGpPWpGaD
Nafcillin—CYP1A2—Xenobiotics—CYP1A1—liver cancer	0.00199	0.00737	CbGpPWpGaD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00198	0.00734	CbGpPWpGaD
Nafcillin—Arthralgia—Doxorubicin—liver cancer	0.00197	0.00386	CcSEcCtD
Nafcillin—Myalgia—Doxorubicin—liver cancer	0.00197	0.00386	CcSEcCtD
Nafcillin—Discomfort—Doxorubicin—liver cancer	0.00195	0.00381	CcSEcCtD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—liver cancer	0.00194	0.0072	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—liver cancer	0.00194	0.0072	CbGpPWpGaD
Nafcillin—CYP1A2—Tamoxifen metabolism—CYP1A1—liver cancer	0.00191	0.00709	CbGpPWpGaD
Nafcillin—Hypotension—Epirubicin—liver cancer	0.00191	0.00373	CcSEcCtD
Nafcillin—Anaphylactic shock—Doxorubicin—liver cancer	0.00189	0.0037	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00186	0.00364	CcSEcCtD
Nafcillin—Shock—Doxorubicin—liver cancer	0.00186	0.00364	CcSEcCtD
Nafcillin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00183	0.0068	CbGpPWpGaD
Nafcillin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00181	0.00671	CbGpPWpGaD
Nafcillin—Hypotension—Doxorubicin—liver cancer	0.00177	0.00346	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Epirubicin—liver cancer	0.00176	0.00345	CcSEcCtD
Nafcillin—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00176	0.00653	CbGpPWpGaD
Nafcillin—Pain—Epirubicin—liver cancer	0.00175	0.00342	CcSEcCtD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—liver cancer	0.00174	0.00646	CbGpPWpGaD
Nafcillin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00172	0.00337	CcSEcCtD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00171	0.00634	CbGpPWpGaD
Nafcillin—Feeling abnormal—Epirubicin—liver cancer	0.00168	0.00329	CcSEcCtD
Nafcillin—Gastrointestinal pain—Epirubicin—liver cancer	0.00167	0.00327	CcSEcCtD
Nafcillin—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.00167	0.00619	CbGpPWpGaD
Nafcillin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00163	0.00319	CcSEcCtD
Nafcillin—CYP1A2—Arachidonic acid metabolism—HPGDS—liver cancer	0.00163	0.00605	CbGpPWpGaD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00163	0.00603	CbGpPWpGaD
Nafcillin—Urticaria—Epirubicin—liver cancer	0.00162	0.00317	CcSEcCtD
Nafcillin—Pain—Doxorubicin—liver cancer	0.00162	0.00316	CcSEcCtD
Nafcillin—Abdominal pain—Epirubicin—liver cancer	0.00162	0.00316	CcSEcCtD
Nafcillin—Body temperature increased—Epirubicin—liver cancer	0.00162	0.00316	CcSEcCtD
Nafcillin—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.0016	0.00593	CbGpPWpGaD
Nafcillin—Feeling abnormal—Doxorubicin—liver cancer	0.00156	0.00305	CcSEcCtD
Nafcillin—CYP1A2—Biological oxidations—UGDH—liver cancer	0.00155	0.00576	CbGpPWpGaD
Nafcillin—Gastrointestinal pain—Doxorubicin—liver cancer	0.00155	0.00302	CcSEcCtD
Nafcillin—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.00153	0.00569	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTA3—liver cancer	0.00153	0.00566	CbGpPWpGaD
Nafcillin—Hypersensitivity—Epirubicin—liver cancer	0.00151	0.00294	CcSEcCtD
Nafcillin—CYP1A2—Estrogen Receptor Pathway—JUN—liver cancer	0.0015	0.00558	CbGpPWpGaD
Nafcillin—Urticaria—Doxorubicin—liver cancer	0.0015	0.00294	CcSEcCtD
Nafcillin—Body temperature increased—Doxorubicin—liver cancer	0.00149	0.00292	CcSEcCtD
Nafcillin—Abdominal pain—Doxorubicin—liver cancer	0.00149	0.00292	CcSEcCtD
Nafcillin—CYP1A2—Melatonin metabolism and effects—CYP1A1—liver cancer	0.00148	0.00547	CbGpPWpGaD
Nafcillin—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.00148	0.00547	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—liver cancer	0.00147	0.00546	CbGpPWpGaD
Nafcillin—Pruritus—Epirubicin—liver cancer	0.00145	0.00283	CcSEcCtD
Nafcillin—CYP1A2—Tryptophan metabolism—CYP2E1—liver cancer	0.00142	0.00527	CbGpPWpGaD
Nafcillin—Diarrhoea—Epirubicin—liver cancer	0.0014	0.00273	CcSEcCtD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.0014	0.00518	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTA4—liver cancer	0.0014	0.00517	CbGpPWpGaD
Nafcillin—Hypersensitivity—Doxorubicin—liver cancer	0.00139	0.00272	CcSEcCtD
Nafcillin—CYP1A2—Phase II conjugation—GSTA2—liver cancer	0.00136	0.00504	CbGpPWpGaD
Nafcillin—Pruritus—Doxorubicin—liver cancer	0.00134	0.00262	CcSEcCtD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00132	0.00489	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTA1—liver cancer	0.00131	0.00487	CbGpPWpGaD
Nafcillin—CYP1A2—Estrogen Receptor Pathway—STAT3—liver cancer	0.0013	0.00482	CbGpPWpGaD
Nafcillin—Vomiting—Epirubicin—liver cancer	0.0013	0.00254	CcSEcCtD
Nafcillin—CYP1A2—Phase II conjugation—NAT2—liver cancer	0.0013	0.00481	CbGpPWpGaD
Nafcillin—Diarrhoea—Doxorubicin—liver cancer	0.00129	0.00253	CcSEcCtD
Nafcillin—Rash—Epirubicin—liver cancer	0.00129	0.00252	CcSEcCtD
Nafcillin—Dermatitis—Epirubicin—liver cancer	0.00129	0.00252	CcSEcCtD
Nafcillin—CYP1A2—Arachidonic acid metabolism—GGT1—liver cancer	0.00122	0.00452	CbGpPWpGaD
Nafcillin—Nausea—Epirubicin—liver cancer	0.00121	0.00237	CcSEcCtD
Nafcillin—Vomiting—Doxorubicin—liver cancer	0.0012	0.00235	CcSEcCtD
Nafcillin—CYP3A4—Biological oxidations—UGDH—liver cancer	0.0012	0.00445	CbGpPWpGaD
Nafcillin—Rash—Doxorubicin—liver cancer	0.00119	0.00233	CcSEcCtD
Nafcillin—Dermatitis—Doxorubicin—liver cancer	0.00119	0.00233	CcSEcCtD
Nafcillin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00119	0.00441	CbGpPWpGaD
Nafcillin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00115	0.00426	CbGpPWpGaD
Nafcillin—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00113	0.0042	CbGpPWpGaD
Nafcillin—Nausea—Doxorubicin—liver cancer	0.00112	0.0022	CcSEcCtD
Nafcillin—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.0011	0.00407	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00105	0.00391	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—HPGDS—liver cancer	0.00104	0.00385	CbGpPWpGaD
Nafcillin—CYP1A2—Tryptophan metabolism—CYP1A1—liver cancer	0.00102	0.00378	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—liver cancer	0.00102	0.00378	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—liver cancer	0.00102	0.00378	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00101	0.00373	CbGpPWpGaD
Nafcillin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000983	0.00364	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000964	0.00358	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000964	0.00358	CbGpPWpGaD
Nafcillin—CYP1A2—Arachidonic acid metabolism—CYP1A1—liver cancer	0.000955	0.00354	CbGpPWpGaD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000931	0.00345	CbGpPWpGaD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000918	0.0034	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000912	0.00338	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—NR1H4—liver cancer	0.000908	0.00337	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTA3—liver cancer	0.000893	0.00331	CbGpPWpGaD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000886	0.00329	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTA3—liver cancer	0.00088	0.00326	CbGpPWpGaD
Nafcillin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000875	0.00324	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.000846	0.00314	CbGpPWpGaD
Nafcillin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000825	0.00306	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTA4—liver cancer	0.000816	0.00303	CbGpPWpGaD
Nafcillin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000814	0.00302	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTA4—liver cancer	0.000805	0.00299	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTA2—liver cancer	0.000796	0.00295	CbGpPWpGaD
Nafcillin—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000788	0.00292	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GGT1—liver cancer	0.000776	0.00288	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTA1—liver cancer	0.000768	0.00285	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—NAT2—liver cancer	0.000759	0.00281	CbGpPWpGaD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000758	0.00281	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	0.000749	0.00278	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000719	0.00266	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000701	0.0026	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTP1—liver cancer	0.000697	0.00259	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000689	0.00255	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000679	0.00252	CbGpPWpGaD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000669	0.00248	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTM1—liver cancer	0.000641	0.00238	CbGpPWpGaD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000637	0.00236	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	0.000636	0.00236	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.00063	0.00234	CbGpPWpGaD
Nafcillin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000629	0.00233	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000627	0.00233	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000621	0.0023	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000614	0.00228	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—HPGDS—liver cancer	0.000607	0.00225	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000592	0.0022	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000586	0.00217	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000578	0.00214	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000575	0.00213	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.000575	0.00213	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000563	0.00209	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000561	0.00208	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000547	0.00203	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000531	0.00197	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000516	0.00191	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—CYP2E1—liver cancer	0.000495	0.00183	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000491	0.00182	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	0.000488	0.00181	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000478	0.00177	CbGpPWpGaD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	0.000477	0.00177	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000468	0.00174	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	0.000465	0.00172	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GGT1—liver cancer	0.000454	0.00168	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.00044	0.00163	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000439	0.00163	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.00041	0.00152	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.00041	0.00152	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTP1—liver cancer	0.000408	0.00151	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000406	0.00151	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000404	0.0015	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	0.000402	0.00149	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000382	0.00142	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000376	0.0014	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTM1—liver cancer	0.000375	0.00139	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	0.00037	0.00137	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000362	0.00134	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—CYP1A1—liver cancer	0.000355	0.00132	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GGT1—liver cancer	0.00035	0.0013	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	0.00035	0.0013	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000349	0.00129	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000346	0.00128	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	0.000326	0.00121	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000315	0.00117	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.00031	0.00115	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000289	0.00107	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000285	0.00106	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000274	0.00102	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.00027	0.001	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000267	0.000988	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—UGDH—liver cancer	0.000266	0.000986	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—EPT1—liver cancer	0.00025	0.000927	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	0.000243	0.000899	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—TAT—liver cancer	0.000237	0.000878	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000233	0.000864	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	0.000219	0.000813	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—UGDH—liver cancer	0.000205	0.000761	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—EPT1—liver cancer	0.000193	0.000715	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—TAT—liver cancer	0.000183	0.000678	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000174	0.000647	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CPT1B—liver cancer	0.000161	0.000597	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GLUL—liver cancer	0.000161	0.000597	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NR1H4—liver cancer	0.000155	0.000576	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTA3—liver cancer	0.000153	0.000566	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTA4—liver cancer	0.00014	0.000518	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000136	0.000506	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTA2—liver cancer	0.000136	0.000505	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTA1—liver cancer	0.000131	0.000487	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NAT2—liver cancer	0.00013	0.000481	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000125	0.000463	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ALDOB—liver cancer	0.000124	0.000461	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CPT1B—liver cancer	0.000124	0.000461	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GLUL—liver cancer	0.000124	0.000461	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NR1H4—liver cancer	0.00012	0.000444	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CRABP1—liver cancer	0.000119	0.00044	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTA3—liver cancer	0.000118	0.000437	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTA4—liver cancer	0.000108	0.0004	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000107	0.000396	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTA2—liver cancer	0.000105	0.000389	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HPGDS—liver cancer	0.000104	0.000385	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000103	0.000383	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTA1—liver cancer	0.000101	0.000376	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NAT2—liver cancer	0.0001	0.000371	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ALDOB—liver cancer	9.6e-05	0.000356	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.4e-05	0.000348	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.28e-05	0.000344	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PSMA4—liver cancer	9.25e-05	0.000343	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PSMD10—liver cancer	9.25e-05	0.000343	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CRABP1—liver cancer	9.16e-05	0.00034	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GOT2—liver cancer	9e-05	0.000334	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP2E1—liver cancer	8.46e-05	0.000314	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.19e-05	0.000304	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HPGDS—liver cancer	8.01e-05	0.000297	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYCS—liver cancer	7.91e-05	0.000293	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GOT1—liver cancer	7.77e-05	0.000288	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GGT1—liver cancer	7.77e-05	0.000288	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PSMA4—liver cancer	7.14e-05	0.000265	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PSMD10—liver cancer	7.14e-05	0.000265	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTP1—liver cancer	6.98e-05	0.000259	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GOT2—liver cancer	6.94e-05	0.000257	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HMOX1—liver cancer	6.88e-05	0.000255	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP2E1—liver cancer	6.53e-05	0.000242	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTM1—liver cancer	6.41e-05	0.000238	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYCS—liver cancer	6.11e-05	0.000226	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP1A1—liver cancer	6.08e-05	0.000225	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GGT1—liver cancer	5.99e-05	0.000222	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GOT1—liver cancer	5.99e-05	0.000222	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—MTHFR—liver cancer	5.67e-05	0.00021	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PPARA—liver cancer	5.56e-05	0.000206	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTP1—liver cancer	5.38e-05	0.0002	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HMOX1—liver cancer	5.31e-05	0.000197	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.99e-05	0.000185	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTM1—liver cancer	4.95e-05	0.000183	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CG—liver cancer	4.76e-05	0.000177	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP1A1—liver cancer	4.69e-05	0.000174	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PPARG—liver cancer	4.59e-05	0.00017	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—MTHFR—liver cancer	4.37e-05	0.000162	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PPARA—liver cancer	4.29e-05	0.000159	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CD—liver cancer	4.18e-05	0.000155	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ALB—liver cancer	4.13e-05	0.000153	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CG—liver cancer	3.67e-05	0.000136	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CB—liver cancer	3.65e-05	0.000135	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PPARG—liver cancer	3.55e-05	0.000131	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CD—liver cancer	3.23e-05	0.00012	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ALB—liver cancer	3.19e-05	0.000118	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CB—liver cancer	2.82e-05	0.000104	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CA—liver cancer	2.22e-05	8.24e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—AKT1—liver cancer	1.82e-05	6.74e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CA—liver cancer	1.72e-05	6.36e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—AKT1—liver cancer	1.4e-05	5.2e-05	CbGpPWpGaD
